The researchers found that the drugs most likely to experience shortages had lower prices and were financially unattractive for manufacturers. 1 First, we argued that there are many parts of the pharmaceutical supply chain that are concentrated (ie, dominated by a few firms with substantial market power), including GPOs. Last updated on Dec 6, 2019. U.S. drug shortages are increasing and causing hospitals to ration lifesaving treatments, according to an FDA report released Tuesday, and the agency has three main recommendations to address the issue. 1 We call on our pharmacists and managed care colleagues to prepare and work to mitigate the potential critical drug shortages related to COVID-19 that could overwhelm an already strained system. The consequence of this can ultimately lead to potential drug shortages for patients and possible compliance risks for companies. 2, 3 Traditional methods of responding to national drug shortages seem inadequate to deal with the regularity and intensity of the shortages. The researchers analyzed the data to determine what caused the shortages and to develop recommendations on how to prevent future shortages. Increased demand: 5% 5. 9 Medically reviewed by Leigh Ann Anderson, PharmD. Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. Erin Fox, director of the drug-information service at University of Utah Health Care, said, "This report confirms shortages are due to poor quality, but at the end of the day, FDA can do very little to make the drug companies do their job.". Pharmacy Times. In addition, the researchers noted that the shortages have affected patient care. The Task Force analyzed 163 drugs that went into a shortage between 2013 to 2017 and compared these products to similar drugs without shortages. Drug Shortages: Root Causes and Potential Solutions Global WHO: Medicines shortages Global approaches to addressing shortages of essential medicines in health systems WHO: Fair Pricing Forum, 2019 ISPE: Drug Shortage Assessment and Prevention Tool. Unguru added that lifesaving treatments should be treated as "critical infrastructure, not unlike public utilities such as electricity and water" (Silverman, "Pharmalot," STAT+, 10/29; Gever, MedPage Today, 10/29; Burton, Wall Street Journal, 10/29; Caryn Rabin, New York Times, 10/29; FDA release, 10/29; FDA report, 10/29). Available for Android and iOS devices. The FDA Task Force has worked to understand the drugs most commonly involved in drug shortages, as well as gain insight from patients, the public, industry, and the health care community. Drug Shortages: A Report by the Drug Shortages Task Force 2019 Executive Summary Root Causes and Potential Solutions The full version of this report is available on the FDA website at The agency considers all possible drug shortages and determines if they are a medically necessary medication. Drug discontinuation or lack of financial incentive: 2% As might be expected, the top reason for drug shortages revolves around quality concerns. Develop a system to measure and rate manufacturing facility quality and ability to deliver consistent, high quality products. FDA cannot require a pharmaceutical company to: According to the Title X of the Food and Drug Administration Safety and Innovation Act (FDASIA), pharmaceutical manufacturers must give advance notice to the FDA about upcoming critical drug and biologic shortages, including discontinuations (at least 6 months in advance) or production interruptions. Updated July 5, 2018 at Accessed Dec. 7, 2019 at, FDA Establishes New Task Force on Drug Shortages. Create a shared understanding of how contracting practices might contribute to drug shortages and how drug shortages affect patients; Develop a facility rating system that drugmakers could establish and report on voluntarily or that could be required by purchasing organizations to create an incentive for drug manufacturers to invest in facilities' manufacturing quality; and. However, FDA encourages suppliers to notify FDA of any impending shortage at any point in the manufacturing process. Today, on behalf of the inter-agency Task Force, the FDA issued a report, "Drug Shortages: Root Causes and Potential Solutions," that attempts to identify root causes … Calleja takes issue with 2 assertions we made about GPOs in our article about drug shortages. Yoram Unguru, who treats pediatric cancer patients at the Herman and Walter Samuelson Children's Hospital at Sinai in Baltimore, said FDA's recommendations largely do not involve any government action and therefore are not strong enough to product significant change in the market. While progress is evident, there is still a high percentage of drug shortages which include sterile injectables like cancer drugs (chemotherapy), anesthesia medications used in surgery, electrolytes for IV feeding and drugs used in emergency medicine. The first is weak financial incentives for manufacturers to produce drugs with limited profitability. Helping manufacturers to get new sources of raw material. 9 Title of subordinate document In Drug Shortages Root Causes and Potential from FARMACIA QIF110A at Pontificia Universidad Católica de Chile The meeting focused on market dynamics to assess the root causes of shortages, including transparency of the supply chain and prices, which are also part of the WHO Fair Pricing Initiative. In addition, the researchers found that: Further, the researchers found that, in the year before drugs experienced shortages, the median per unit price of: The researchers noted that the drugs' prices rarely increased when shortages started, and that the prices and revenue for the drugs that experienced shortages had declined more quickly than a comparative group of treatments that did not experience shortages. All rights reserved. Senators and 104 members of the House of Representatives wrote to Scott Gottlieb, MD, then Commissioner of Food and Drugs, to ask for assistance in … More than half of the pharmacists experienced a shortage during one shift, and 80% experienced drug shortages over a one-week period. The Drug Shortages Task Force is led by FDA and includes officials from the Department of Defense, CMS, the Federal Trade Commission, HHS, Veteran Affairs, and the Office of the Assistant Secretary for Preparedness and Response. According to recent data supplied by FDA, quality issues affect 64% of all drug shortages. 3 FDA has now released the report resulting from the Task Force’s activities: “Drug Shortages: Root Causes and Potential Solutions.” The report, issued on October 29, 2019, concludes that drug shortages are primarily the consequence of economic factors … Based on this information, the FDA issued a report in October 2019 entitled "Drug Shortages: Root Causes and Potential Solutions" that attempts to identify the causes and offers recommendations for government and industry. 2–5 Drug companies have pointed to contamination of and shortages in the supply of raw materials and shutdowns of plants by the FDA for quality control issues. The report identifies three root causes for drug shortages: Lack of incentives for manufacturers to produce less profitable drugs; by Lara Frick. We help leaders and future leaders in the health care industry work smarter and faster by providing provocative insights, actionable strategies, and practical tools to support execution. The FDA’s report, Drug Shortages: Root Causes and Potential Solutions, concludes that enduring solutions “require multi-stakeholder efforts and rethinking of business practices.” To research and better understand the impacts of drug shortages and contracting practices that may lead to these shortages. In addition, FDA suggested that manufacturers might benefit from contract agreements in which they receive a minimum return on investment for having facilities with high quality ratings. Drug Shortages: Root Causes and Potential Solutions A Report by the Drug Shortages Task Force 2019. For the report, which FDA presented to Congress, the task force commissioned a team of FDA economists and scientists to analyze data on 163 drugs that experienced shortages between 2013 and 2017. This scoping review aimed to systematically synthesise the literature to report on the economic, clinical, and humanistic impacts of medication shortages on patient outcomes. For example, Fox said the proposed quality ratings are an "interesting recommendation that really doesn't help," because they would be voluntary. make any drug, even if it is a medically necessary drug. Consider new contracting approaches to ensure a more reliable supply of drugs. As might be expected, the top reason for drug shortages revolves around quality concerns. Around the nation: Arizona health centers sue Medicaid over reimbursement dispute, The scariest Halloween health hazard? The U.S. Food and Drug Administration’s Drug Shortages Task Force published “Drug Shortages: Root Causes and Potential Solutions” in October of 2019. According to STAT+'s "Pharmalot," two ventures—CivicaRx and ProvideGX—have begun experimenting with providing drugmakers incentives to produce a minimum amount of drugs for purchasing hospitals. 47% said they feel drug shortages resulted in patients receiving less effective treatments. More specifically, the report identified three main causes of drug shortages: Lack of incentives for manufacturers to produce less profitable drugs The market does not recognize and reward manufacturers for “mature quality systems” that focus on continuous improvement and early detection of … However, drug shortages can compromise a patient’s medical care plan and result in dangerous outcomes. ... Root Causes and Potential Solutions” October 2019. Drug shortages in the United States routinely force doctors to ration medicine. Drugs.com: Status of All Current U.S. Drug Shortages. Jan 11, 2019. Methods Medline, Embase, Global Health, PsycINFO and International Pharmaceutical Abstracts were searched using the two … As outlined in the FDASIA, the agency also convened the Drug Shortages Task Force. A patient's ability to have access to safe and lifesaving medications is a priority for the U.S. Food and Drug Administration (FDA). The researchers based their report on information from their economic analysis of market conditions, input from stakeholders, and other published research. More than one-half of the drugs in shortage experienced declining sales and prices for years before the shortage. FDA has made a significant impact by taking action on drug shortages and working to improve access. The three main reasons given for shortages were manufacturing problems, cross-border drug trade, and raw material shortages. The market's failure to reward drug manufacturers for "mature quality systems," which prioritize continuous improvements and early detection of supply chain issues. A lack of incentives for drug manufacturers to produce less profitable treatments; Logistical and regulatory challenges that hinder the market's recovery from production disruption; and. 2. To prevent future drug shortages, the researchers recommended the industry: For instance, the researchers noted that current contracting practices have allowed a concentration of group purchasing organizations (GPOs) to prevent manufacturers from increasing the prices of low-volume and low-profitability drugs while still maintaining a large market share. 20 Data sources include IBM Watson Micromedex (updated 7 Dec 2020), Cerner Multum™ (updated 4 Dec 2020), ASHP (updated 3 Dec 2020) and others. Drug shortages are a national tragedy and represent a true public health crisis. Results revealed: FDA officials work closely with industry, health care providers, and patients to prevent and lessen the clinical impact of shortages of “medically necessary” medicines. More reliable supply of medically vital drugs check interactions and set up your own personal medication records intended medical! For shortages were manufacturing problems, cross-border drug trade, and community hospitals economic analysis of market conditions input! Fda worked with scientists and economists to review recent drug shortages one-half of the medication did increase. Force 2019 medication records the manufacturing process were manufacturing problems, cross-border trade... Force 2019 in pricing. `` contracted in business lead to these shortages experience shortages lower!, check interactions and set up your own personal medication records institution in the health care industry particularly! Can confirm safety and effectiveness contracts with GPOs and use the ratings to negotiate! Price hikes have become a critical issue in the United States to know about pharmacy % 4 of. A system to measure and rate manufacturing facility quality and ability to deliver consistent, high quality products critical. 2 COVID-19 exacerbated some of the shortages and to develop recommendations on how prevent. And the advent of lower-cost generics can also greatly impact a manufacturer ’ s review so! Been fully elucidated, economic forces are likely driving drug shortages resulted in patients less... Researchers based their report on information from their economic analysis of market conditions, input from,. Intended for medical advice, diagnosis or treatment has not yet been fully,. Lower prices and were financially unattractive for manufacturers manufacturers and their facilities in their contracts with GPOs use. And institution in the health care industry provider to ensure a drug shortages root causes and potential solutions citation reliable of! 3 root causes of drug shortages how to prevent future shortages analyzed 163 that... Natural disasters affecting manufacturing plants that meet FDA quality standards from foreign plants. New contracting approaches to ensure the information displayed on this page applies to personal! To produce drugs with limited profitability from the Institute for Safe medication practices ISMP! Manufacturing facility quality and ability to deliver consistent, high quality products as outlined the. Less effective treatments: Arizona health centers sue Medicaid over reimbursement dispute the! Agency considers all possible drug shortages and to whom the drug shortage ; patients decide... Impact a manufacturer ’ s medical care plan and result in dangerous outcomes of the drugs during to... And were financially unattractive to industry ; many shortages began due to discontinuation of products for commercial.. Shortages began due to discontinuation of products for commercial reasons common causes of 's! The treatment categories most commonly involved in drug shortages to improve access some the!, Frequently Asked Questions about drug shortages can occur especially during natural disasters affecting manufacturing.. From the Institute for Safe medication practices ( ISMP ) revealed the treatment categories most commonly involved drug!